 testolacton sulindac warfarin vitamin unresect desmoid tumor patient larg inoper desmoid tumor variou bodi locat testolacton tumor major regress reduct volum patient nonsteroid anti-inflammatori drug indomethacin sulindac sulindac warfarin vitamin mephyton period month major regress partial regress instanc tumor growth arrest period year patient nonsteroid anti-inflammatori drug concurr testolacton tamoxifen major regress partial regress extens central necrosi enorm intra-abdomin tumor last patient month chang tumor volum function growth factor desmoid tumor minim effect inhibit tumor growth case instanc antiestrogen effect singl agent tumor subsequ nonsteroid anti-inflammatori drug therapi withdraw estrogen inhibit transcript gene tumor cell prolifer sulindac indomethacin effect prostaglandin cyclic amp synthesi activ protein kinas warfarin protonophor cytoplasm alkalin necessari dna synthesi cell cycl progress impair transcript process